Five Prime Therapeutics, Inc. Debt to Equity Ratio 2013-2020 | FPRX
Current and historical debt to equity ratio values for Five Prime Therapeutics, Inc. (FPRX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Five Prime Therapeutics, Inc. debt/equity for the three months ending December 31, 2020 was .
| Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2020-12-31 | $0.07B | $0.27B | 0.25 |
| 2020-09-30 | $0.07B | $0.10B | 0.68 |
| 2020-06-30 | $0.07B | $0.12B | 0.55 |
| 2020-03-31 | $0.07B | $0.14B | 0.51 |
| 2019-12-31 | $0.07B | $0.15B | 0.49 |
| 2019-09-30 | $0.08B | $0.18B | 0.45 |
| 2019-06-30 | $0.09B | $0.21B | 0.42 |
| 2019-03-31 | $0.08B | $0.23B | 0.35 |
| 2018-12-31 | $0.06B | $0.27B | 0.21 |
| 2018-09-30 | $0.07B | $0.30B | 0.23 |
| 2018-06-30 | $0.06B | $0.34B | 0.18 |
| 2018-03-31 | $0.07B | $0.36B | 0.21 |
| 2017-12-31 | $0.08B | $0.27B | 0.30 |
| 2017-09-30 | $0.07B | $0.29B | 0.25 |
| 2017-06-30 | $0.06B | $0.32B | 0.18 |
| 2017-03-31 | $0.05B | $0.36B | 0.15 |
| 2016-12-31 | $0.06B | $0.39B | 0.15 |
| 2016-09-30 | $0.06B | $0.40B | 0.15 |
| 2016-06-30 | $0.07B | $0.43B | 0.17 |
| 2016-03-31 | $0.08B | $0.43B | 0.19 |
| 2015-12-31 | $0.12B | $0.43B | 0.27 |
| 2015-09-30 | $0.07B | $0.13B | 0.55 |
| 2015-06-30 | $0.07B | $0.15B | 0.48 |
| 2015-03-31 | $0.07B | $0.16B | 0.45 |
| 2014-12-31 | $0.07B | $0.09B | 0.83 |
| 2014-09-30 | $0.04B | $0.10B | 0.44 |
| 2014-06-30 | $0.05B | $0.10B | 0.45 |
| 2014-03-31 | $0.05B | $0.11B | 0.41 |
| 2013-12-31 | $0.02B | $0.06B | 0.41 |
| 2013-09-30 | $0.03B | $0.07B | 0.42 |
| 2013-06-30 | $0.00B | 0.00 | |
| 2013-03-31 | $0.00B | 0.00 | |
| 2012-09-30 | $0.00B | 0.00 | |
